Jose Bautista hit his 19th home run last night, helping power the Blue Jays past the Yankees. The game and its aftermath is making me want to take a walk down memory lane.
For instance, remember back in 2009 when speculating that an unusual spike in a player’s performance could be steroids-related would get you torn a new one by virtually every credentialed writer in baseball and featured in a public pillorying on ESPN for your lack of journalistic ethics?
Wait, maybe I dreamed that, because there is no way that could have happened and this article in the Daily News could still appear without a similar outrage. That would be crazy!
Bautista is the power-hitting sensation the sport desperately needs these days.
Let’s hope he’s clean.
Sorry, but even in this drug-testing era, it’s impossible not to be suspicious when someone suddenly starts hitting the ball to the moon in his late 20s. Unfortunately, steroids forever hardened us to the romance of a late-bloomer like Bautista, especially when baseball still has no test for human growth hormone … Bautista is a great story. Let’s just hope he’s legit.
One more walk down memory lane: remember when, back in 2003 or so, baseball writers used to say that unless and until there is steroid testing in baseball, everyone will be under suspicion? How then, is it possible, seven years after the imposition of steroid testing, for them to still be under the same suspicion? Is there absolutely no basic, prima facie presumption of innocence? Is there not anything apart from the mere hitting of some home runs, that is required before this kind of skepticism and innuendo is warranted?
Confirming a report from Tuesday, the Diamondbacks officially signed right-hander Fernando Rodney to a one-year, $2.75 million contract on Friday. The 39-year-old stands to receive up to $4 million in incentives, per Jack MacGruder of FanRag Sports, with $250,000 kicking in when the veteran reaches 40, 50 and 60 appearances and $500,000 if he reaches 70.
Rodney came three games shy of the 70-appearance mark in 2016 during back-to-back stints with the Padres and Marlins. He put up a cumulative 3.44 ERA on the year, which effectively disguised the extreme split during his performances in San Diego and Miami. The Diamondbacks aren’t anywhere close to contending in 2017, but Rodney should stabilize the back end of their bullpen while providing Arizona GM Mike Hazen with a potential trade chip during next year’s deadline.
Hazen issued a statement following the signing:
With Fernando, we’re getting an established Major League closer and a veteran presence in the bullpen. It is helpful to have someone with his experience on the back end to slow the game down and get the final three outs.
The Cardinals have officially signed outfielder Dexter Fowler to a five-year, $82.5 million contract. Fowler will also get a full no-trade clause.
The Cardinals gave Fowler a bigger deal than many speculated he’d get, as some reports predicted he’d get something in the $52-72 million range. His skills, however — he’s a fantastic leadoff hitter who plays a premium defensive position — definitely earned him some major dough. Fowler hit .276/.393/.447 with 13 homers, 48 RBI and 13 steals over 125 games in 2016 for the World Series champion Cubs.
For the Cardinals, this will allow Matt Carpenter to move down to the middle of the batting order and will shift Randal Grichuk to left field. It also takes a prime piece from the Cardinals’ biggest rival. For their part, earlier this offseason the Cubs signed former Cardinal center fielder Jon Jay. So that’s fun.